Profiling Protein Arginine Deiminase 4 (PAD4): A novel screen to identify PAD4 inhibitors
- 13 October 2007
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 16 (2), 739-745
- https://doi.org/10.1016/j.bmc.2007.10.021
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Protein Arginine Deiminase 4: Evidence for a Reverse Protonation MechanismBiochemistry, 2007
- Activity-Based Protein Profiling Reagents for Protein Arginine Deiminase 4 (PAD4): Synthesis and in vitro Evaluation of a Fluorescently Labeled ProbeJournal of the American Chemical Society, 2006
- Inhibitors and Inactivators of Protein Arginine Deiminase 4: Functional and Structural Characterization,Biochemistry, 2006
- Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrationsProceedings of the National Academy of Sciences, 2006
- A Fluoroacetamidine-Based Inactivator of Protein Arginine Deiminase 4: Design, Synthesis, and in Vitro and in Vivo EvaluationJournal of the American Chemical Society, 2006
- Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivityBioorganic & Medicinal Chemistry Letters, 2005
- Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritisNature Genetics, 2003
- Therapeutic strategies for rheumatoid arthritisNature Reviews Drug Discovery, 2003
- Discovering potent and selective reversible inhibitors of enzymes in complex proteomesNature Biotechnology, 2003
- Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.JCI Insight, 1998